01 March 2004
Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma groupJerzy R. Kowalczyk, Joanna Nurzyńska, Jerzy Armata, Janina Bogusławska-Jaworska, Roma Rokicka-Milewska, Danuta Sońta-Jakimczyk, Walentyna Balwierz, Alicja Chybicka, Małgorzata Kaczmarek-Kanold, Jacek Wachowiak, Michał Matysiak, Katarzyna Pawelec
Med Sci Monit 2004; 10(3): CR117-122 :: ID: 11596
Background:The development of second malignant neoplasms (SMNs) in patients receiving chemotherapy and radiation therapy for primary cancers is one of the limitations to the quality and length of survival. The present study was undertaken to examine various characteristics of children who developed SMNs following successful therapy for primary leukemia or Hodgkin’s disease (HD).Material/Methods: A total of 3252 children with various forms of leukemia and 849 children with HD treated between, 1970–1997 at 7 pediatric centers of the Polish Pediatric Hematology/Oncology Group and subsequently followed-up entered the study. A second malignancy was diagnosed in 36 of these children.Results: Of the 3252 patients diagnosed as having acute leukemia during this period, 16 developed SMNs (estimated frequency 0.49%). SMNs developed in 20 of the 849 children treated for HD (2.36%). The most frequent SMNs were soft tissue sarcoma and thyroid carcinomas, mainly following Hodgkin’s disease. Other tumors occurred at about the same frequencies in both groups. The interval from the end of initial treatment to diagnosis of an SMN ranged from 2 years 7 months to 17 years 6 months, with a median of 7 yrs 4 mo. for acute lymphoblastic leukemia (ALL) patients and 10 years for children with HD. The estimated accumulated risk of SMN following acute leukemia is 0.95% at 15 years and, for HD, 5.1% at 20 yrs and 7% at 25 yrs.Conclusions: Children who have been successfully treated for one cancer have a higher than expected incidence of additional tumors.
Keywords: Adolescent, Child, Child, Preschool, Follow-Up Studies, Hodgkin Disease - pathology, Hodgkin Disease - therapy, Incidence, Leukemia - pathology, Leukemia - therapy, Leukemia, Lymphocytic, Acute - pathology, Leukemia, Lymphocytic, Acute - therapy, Neoplasms, Second Primary - diagnosis, Neoplasms, Second Primary - epidemiology, Sarcoma - secondary, Soft Tissue Neoplasms - secondary, Thyroid Neoplasms - secondary, Time Factors, Adolescent, Child, Child, Preschool, Follow-Up Studies, Hodgkin Disease - therapy, Incidence, Leukemia - therapy, Neoplasms, Second Primary - epidemiology, Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy, Sarcoma - secondary, Soft Tissue Neoplasms - secondary, Thyroid Neoplasms - secondary, Time Factors
01 June 2023 : EditorialEditorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness
Med Sci Monit 2023; 29:e941209
01 Jun 2023 : Clinical ResearchRoot Canal Numbers and Configurations in 1080 Permanent Canine Teeth in 270 Saudi Subjects Using Cone-Beam ...
Med Sci Monit In Press; DOI: 10.12659/MSM.940472
01 Jun 2023 : Clinical ResearchInternal Orifice Alloy Closure: A New Procedure for Treatment of Perianal Fistulizing Crohn’s Disease
Med Sci Monit In Press; DOI: 10.12659/MSM.940873
01 Jun 2023 : Clinical ResearchEffectiveness of Needle Aspiration versus Surgical Excision for Symptomatic Synovial Cysts of the Hip: A Si...
Med Sci Monit In Press; DOI: 10.12659/MSM.940187
01 Jun 2023 : Clinical ResearchInfluence of Insulin Resistance on Diabetes Nephropathy
Med Sci Monit In Press; DOI: 10.12659/MSM.939482
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952